Journey Advisory Group’s Vanguard Health Care ETF VHT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$256K Sell
941
-10
-1% -$2.86K 0.02% 224
2025
Q4
$274K Sell
951
-110
-10% -$30.7K 0.02% 232
2025
Q3
$275K Sell
1,061
-60
-5% -$15.1K 0.02% 239
2025
Q2
$278K Hold
1,121
0.02% 249
2025
Q1
$297K Sell
1,121
-513
-31% -$137K 0.02% 239
2024
Q4
$435K Hold
1,634
0.05% 165
2024
Q3
$435K Hold
1,634
0.05% 165
2024
Q2
$435K Sell
1,634
-398
-20% -$104K 0.05% 165
2024
Q1
$550K Buy
2,032
+115
+6% +$30.2K 0.07% 154
2023
Q4
$481K Sell
1,917
-100
-5% -$23.7K 0.07% 151
2023
Q3
$474K Hold
2,017
0.07% 146
2023
Q2
$494K Hold
2,017
0.07% 150
2023
Q1
$481K Buy
2,017
+224
+12% +$53.9K 0.08% 152
2022
Q4
$445K Sell
1,793
-55
-3% -$13.3K 0.11% 137
2022
Q3
$413K Buy
1,848
+50
+3% +$11.9K 0.11% 160
2022
Q2
$437K Buy
+1,798
New +$433K 0.1% 165

Other funds holding VHT

Journey Advisory Group's VHT Position: Q1 2026 in Review

Journey Advisory Group reduced its Vanguard Health Care ETF (VHT) stake by 1.1% in Q1 2026, selling an estimated $2.86K and leaving 941 shares worth $256K. The position accounts for 0.02% of the portfolio, ranked #224.

Journey Advisory Group first reported a position in VHT in Q2 2022 and has held it in 16 quarters since. The position peaked at $550K in Q1 2024. 1,085 funds tracked by Wall St. Rank hold VHT as of Q1 2026.

  • Journey Advisory Group held 941 shares of Vanguard Health Care ETF worth $256K as of Q1 2026.
  • Journey Advisory Group sold 10 Vanguard Health Care ETF shares in Q1 2026, an estimated $2.86K.
  • Vanguard Health Care ETF made up 0.02% of Journey Advisory Group's portfolio in Q1 2026, its #224 holding.
  • Journey Advisory Group first reported a position in Vanguard Health Care ETF in Q2 2022 and has held it in 16 quarters since.
  • Journey Advisory Group's Vanguard Health Care ETF position peaked at $550K in Q1 2024.
  • 1,085 funds tracked by Wall St. Rank held Vanguard Health Care ETF as of Q1 2026.

Based on Journey Advisory Group's 13F filing for Q1 2026, filed 5 May 2026.